Survivorship in the Era of Immunotherapy
Advances in immunotherapy (IO) have shown promising outcomes for subsets of patients that have been resistant to convention treatment. However, these patients have also experience late physical and psychosocial effects of cancer and its treatment, such as depression, pain or fatigue, which negatively impacts their quality of life.
The Association of Community Cancer Centers (ACCC) has released a two-part webinar / lecture series with supporting resources to address this topic. You can view both videos below or CLICK HERE to access the online resources.
